ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ABCL AbCellera Biologics Inc

4.0599
0.2099 (5.45%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
AbCellera Biologics Inc ABCL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.2099 5.45% 4.0599 13:00:00
개장가 저가 고가 종가 전일 종가
3.92 3.92 4.20 4.03 3.85
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202422:00BWAbCellera, Viking Global Investors, and ArrowMark Partners..
09/04/202401:05BWAbCellera Presents Data on T-Cell Engagers Against Four..
04/04/202405:05BWAbCellera to Report First Quarter 2024 Financial Results on..
20/03/202405:05BWAbCellera to Present at the Bloom Burton Healthcare..
11/03/202422:00BWAbCellera to Collaborate with Biogen to Discover Therapeutic..
06/03/202406:30BWAbCellera Announces Four Presentations on T-Cell Engagers at..
28/02/202404:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:49EDGAR2Form 8-K - Current report
24/02/202406:30BWAbCellera Announces Resignation of Board Member
23/02/202410:15BWAbCellera to Present at Upcoming Investor Conferences in..
21/02/202406:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/02/202406:27EDGAR2Form 8-K - Current report
21/02/202406:05BWAbCellera Reports Full Year 2023 Business Results
24/01/202406:05BWAbCellera to Report Full Year 2023 Financial Results on..
17/01/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202408:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:05BWAbCellera to Present at the 42nd Annual J.P. Morgan..
20/12/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202307:28EDGAR2Form 8-K - Current report
28/11/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202306:05BWAbCellera to Present at the Piper Sandler 35th Annual..
09/11/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202301:05BWAbCellera Presents New Data on Two T-Cell Engager Programs..
03/11/202305:13EDGAR2Form 8-K - Current report
03/11/202305:05BWAbCellera Reports Q3 2023 Business Results
02/11/202305:05BWPrelude Therapeutics and AbCellera Enter Partnership to..
01/11/202305:05BWAbCellera to Present at the Jefferies London Healthcare..
12/10/202305:05BWAbCellera to Report Third Quarter 2023 Financial Results on..
27/09/202322:00BWAbCellera Announces Two T-Cell Engager Presentations at SITC..
21/09/202306:02BWAbCellera Expands Multi-Target Antibody Discovery..
20/09/202322:00BWAbCellera Expands Multi-Target Antibody Discovery..
15/09/202305:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202322:00BWAbCellera Announces Collaboration with Incyte to Accelerate..
26/08/202302:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:15EDGAR2Form 8-K - Current report
04/08/202305:05BWAbCellera Reports Q2 2023 Business Results
25/07/202305:05BWAbCellera Announces that the U.S. Patent Trial and Appeal..
07/07/202305:05BWAbCellera to Report Second Quarter 2023 Financial Results on..
30/05/202305:05BWAbCellera to Present at the Goldman Sachs 44th Annual Global..
25/05/202302:10BWAbCellera Partners with the Governments of Canada and..

최근 히스토리

Delayed Upgrade Clock